Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, December 09, 2025
Under the agreement, GNX will serve as the CDMO partner, providing GMP grade drug substance manufacturing and regulatory support to enable initiation of a Phase 1/2a clinical trial in Japan of CC001, an investigational anti-HMGB1 monoclonal antibody ...
read more
Tuesday, December 09, 2025
Andelyn Biosciences has partnered with Jaguar Gene Therapy to perform late-stage Process Performance Qualification (PPQ) manufacturing of JAG201, an investigational gene therapy targeting SHANK3 haploinsufficiency which is clinically diagnosed as ...
read more
Monday, December 08, 2025
Quotient Sciences and Intrepid Labs announced a multi-year strategic partnership to advance the use of artificial intelligence (AI) in early drug development.
read more
Monday, December 08, 2025
SeaBeLife has signed a joint development agreement with Unither Pharmaceuticals for the production of clinical and commercial batches of the topical ophthalmic formulation of the SBL03 drug candidate. SBL03 is intended to treat degenerative disorders...
read more
Thursday, December 04, 2025
Vetter announced the retirement of its Managing Director Thomas Otto after more than 35 years at the company. He will step down at the end of 2025.
read more
Thursday, December 04, 2025
Cellipont Bioservices announced the completion of its ballroom-style cleanroom, featuring a state-of-the-art 50-liter single-use bioreactor. This facility expansion marks a major milestone in Cellipont's continued investment to meet the growing ...
read more
Thursday, December 04, 2025
Benuvia Operations announced a strategic partnership with Cannovation Clinical Research Partners (CCRP), a global consultancy focused on cannabinoid and psychedelic therapeutic programs. Together, the organizations will create the industry's first ...
read more
Wednesday, December 03, 2025
Emerald Clinical Trials announced the appointment of Luke Gill, MSc, MBA, as Vice President, Global Head of Oncology, Medical & Scientific Affairs. This appointment underscores Emerald's continued investment in advancing oncology innovation and ...
read more
Wednesday, December 03, 2025
Avance Biosciences announced the opening of its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company's capabilities in potency and functional cell-based assays under GMP ...
read more
Tuesday, December 02, 2025
eXmoor Pharma and the Translational Research Office (TRO) at University College London (UCL) have formed a strategic collaboration to accelerate the development of novel cell and gene therapies (CGTs) from academic research into clinical application.
read more
Tuesday, December 02, 2025
WuXi Biologics announced that it has signed a strategic Memorandum of Understanding (MoU) with the Qatar Free Zones Authority (QFZ) to extend WuXi Biologics' global network and capabilities to the Middle East.
read more
Tuesday, December 02, 2025
Piramal Pharma Solutions announced the successful completion of its journey to compliance with global requirements for nitrosamine impurities in pharmaceuticals.
read more
Tuesday, December 02, 2025
Rentschler Biopharma and Coriolis Pharma announced a strategic collaboration which will offer seamless, end-to-end solutions from early formulation through to commercial manufacturing, combining their complementary expertise to accelerate product’s ...
read more
Tuesday, November 25, 2025
Under this collaboration, Cellergy Therapeutics will leverage Made Scientific's GMP manufacturing capabilities to implement and scale Cellergy's proprietary mitochondrial isolation and purification process. The work will support the production of ...
read more
Tuesday, November 25, 2025
Under this agreement AGC Biologics will provide Good Manufacturing Practice manufacturing for AAVantgarde’s two novel candidates designed to address progressive and irreversible vision loss where there are currently no approved therapies.
read more